1.Guidelines for Antibacterial Treatment of Carbapenem-Resistant Enterobacterales Infections
Se Yoon PARK ; Yae Jee BAEK ; Jung Ho KIM ; Hye SEONG ; Bongyoung KIM ; Yong Chan KIM ; Jin Gu YOON ; Namwoo HEO ; Song Mi MOON ; Young Ah KIM ; Joon Young SONG ; Jun Yong CHOI ; Yoon Soo PARK ; Korean Society for Antimicrobial Therapy
Infection and Chemotherapy 2024;56(3):308-328
This guideline aims to promote the prudent use of antibacterial agents for managing carbapenem-resistant Enterobacterales (CRE) infections in clinical practice in Korea. The general section encompasses recommendations for the management of common CRE infections and diagnostics, whereas each specific section is structured with key questions that are focused on antibacterial agents and disease-specific approaches. This guideline covers both currently available and upcoming antibacterial agents in Korea.
2.Guidelines for Antibacterial Treatment of Carbapenem-Resistant Enterobacterales Infections
Se Yoon PARK ; Yae Jee BAEK ; Jung Ho KIM ; Hye SEONG ; Bongyoung KIM ; Yong Chan KIM ; Jin Gu YOON ; Namwoo HEO ; Song Mi MOON ; Young Ah KIM ; Joon Young SONG ; Jun Yong CHOI ; Yoon Soo PARK ; Korean Society for Antimicrobial Therapy
Infection and Chemotherapy 2024;56(3):308-328
This guideline aims to promote the prudent use of antibacterial agents for managing carbapenem-resistant Enterobacterales (CRE) infections in clinical practice in Korea. The general section encompasses recommendations for the management of common CRE infections and diagnostics, whereas each specific section is structured with key questions that are focused on antibacterial agents and disease-specific approaches. This guideline covers both currently available and upcoming antibacterial agents in Korea.
3.Guidelines for Antibacterial Treatment of Carbapenem-Resistant Enterobacterales Infections
Se Yoon PARK ; Yae Jee BAEK ; Jung Ho KIM ; Hye SEONG ; Bongyoung KIM ; Yong Chan KIM ; Jin Gu YOON ; Namwoo HEO ; Song Mi MOON ; Young Ah KIM ; Joon Young SONG ; Jun Yong CHOI ; Yoon Soo PARK ; Korean Society for Antimicrobial Therapy
Infection and Chemotherapy 2024;56(3):308-328
This guideline aims to promote the prudent use of antibacterial agents for managing carbapenem-resistant Enterobacterales (CRE) infections in clinical practice in Korea. The general section encompasses recommendations for the management of common CRE infections and diagnostics, whereas each specific section is structured with key questions that are focused on antibacterial agents and disease-specific approaches. This guideline covers both currently available and upcoming antibacterial agents in Korea.
4.Analysis of overcrowding indices of isolation beds at a single regional emergency department in the COVID-19 pandemic era
San LEE ; Jin Hyun YOO ; So Mi SHIN ; Hyun Woong NOH ; Yun Jun KIM ; Dong Hun KWAK ; Hyung Soo KIM ; Ik Chang CHOI ; Min Gu SEO
Journal of the Korean Society of Emergency Medicine 2024;35(2):181-191
Objective:
Emergency department (ED) overcrowding is a global issue that negatively impacts the clinical outcome. Through the coronavirus disease 2019 (COVID-19) pandemic era, overcrowding of ED isolated territory (isolation bed) was aggravated. This study analyzed overcrowding indices of ED isolation beds during the COVID-19 pandemic.
Methods:
This study was a single-center, retrospective, observational study. The study analyzed 34,925 patients who visited the ED during the COVID-19 pandemic from April 2021 to August 2022. Patients who were treated in isolation beds and regular beds were compared. Among the patients using isolation beds, patients who stayed longer than 720 minutes were also classified and analyzed.
Results:
During the analysis period, 4,479 and 34,943 patients were treated in the ED isolation bed and ED regular bed, respectively. The overcrowding indices (general ward admission rate, intensive care unit admission rate, ED-length of stay, transfer rate, mortality rate, prolonged ED stay patient ratio) of the isolation beds were significantly higher than those of the ED regular bed (P<0.05). The prolonged ED stay-patient ratio of isolation beds and regular beds was affected by the number of COVID-19 patients (regular bed, r=0.617 and P=0.01; isolation bed, r=0.525 and P=0.03). The average ED-length of stay of isolation beds was longer than that of the ED regular beds. One hundred and forty-five patients were classified as prolonged ED stay patients. Their time from the decision point to the discharge point comprised a higher rate with an average of 76.52%.
Conclusion
ED isolation beds are more vulnerable to infectious disease outbreaks. A proper medical policy and arrangement management system that can flexibly deal with disaster emergencies are required
5.Molecular detection of Borrelia theileri in cattle in Korea
Hyeon-Ji HYUNG ; Yun-Sil CHOI ; Jinho PARK ; Kwang-Jun LEE ; Jun-Gu KANG
Parasites, Hosts and Diseases 2024;62(1):151-156
Bovine borreliosis, caused by Borrelia theileri which is transmitted via hard tick bites, is associated with mild clinical symptoms, such as fever, lethargy, hemoglobinuria, anorexia, and anemia. Borrelia theileri infects various animals, such as cattle, deer, horses, goats, sheep, and wild ruminants, in Africa, Australia, and South America. Notably, no case of B. theileri infection has been reported in Korean cattle to date. In this study, 101 blood samples were collected from a Korean indigenous cattle breed, among which 1.98% tested positive for B. theileri via nested PCR. The obtained sequences exhibited high homology with B. theileri strains identified in other regions. Phylogenetic analysis of 16S rRNA confirmed the B. theileri group affiliation; however, flagellin B sequences exhibited divergence, potentially due to regional evolutionary differences. This study provides the first molecular confirmation of B. theileri infection in Korean livestock. Further isolation and nucleotide sequence analyses are necessary to better understand the presence of B. theileri strains in cows in Korea.
6.Fixed Drug Eruption in a Patient Taking Valacyclovir without Cross-Reactivity to Acyclovir
Yeon-Gu CHOI ; Hyeon Jeong PARK ; Sunmin YIM ; Heun Joo LEE ; Young Jun CHOI ; Won-Serk KIM ; Ga-Young LEE
Annals of Dermatology 2023;35(Suppl1):S55-S58
Fixed drug eruption (FDE) is a well-defined hyperpigmented patch that recurs in a fixed location each time a particular drug is taken. Common causative agents of FDE are nonsteroidal anti-inflammatory drugs, non-narcotic analgesics, sedatives, anticonvulsants, sulfonamides, and tetracycline. We report a 33-year-old male who presented with a recurrent, localized, brownish-to-erythematous macule and papules on the peri-philtrum area two hours after taking valacyclovir. Three episodes of valacyclovir ingestion for treatment of Herpes simplex virus infection provoked a similar skin rash at the same site. Histopathology results showed vacuolar degeneration in the basal layer of the epidermis, pigmentary incontinence, and perivascular inflammatory cell infiltration in the papillary dermis. Although patch test and skin prick test showed negative responses to acyclovir and valacyclovir, an intradermal test showed a positive reaction only to valacyclovir. The oral provocation test to acyclovir and valacyclovir showed a positive reaction only to valacyclovir. Through drug history, histopathological examination, patch test, intradermal test, and oral provocation test, we established a final diagnosis of FDE due to valacyclovir without cross-reactivity to acyclovir. To find alternative therapeutic drugs, we suggest diagnostic tests with not only the suspected drugs, but also other drugs in the same class.
8.Comparison of the intubation performance of video laryngoscopes with and without a channel during the intubation training for EMT students wearing Level-D PPE
Hyeon-Jun JO ; Yoonje LEE ; Gu Hyun KANG ; Yong Soo JANG ; Wonhee KIM ; Hyun Young CHOI ; Jae Guk KIM
Journal of the Korean Society of Emergency Medicine 2023;34(2):144-153
Objective:
The purpose of this study was to determine the type of video laryngoscope training that is appropriate for emergency medical technicians (EMT) familiar with direct laryngoscopes, to prepare them for tracheal intubation while they are wearing personal protective equipment (PPE).
Methods:
Thirty-eight healthy EMTs were recruited. The participants underwent two tests with four different laryngoscopes: Macintosh, McGrath, Pentax Airway Scope (PENTAX-AWS), and A-LRYNGO. The first test was conducted just after a lecture without any hands-on workshops. The second test was conducted after a hands-on workshop. In each test, we measured the time required for tracheal intubation, intubation success rate, etc., and asked all the participants to respond to a short questionnaire.
Results:
The time to complete the insertion of the endotracheal tube with the Macintosh laryngoscope did not significantly change (P=0.098), but the rest of the outcomes significantly improved after the hands-on workshop (all P<0.05). Despite the unfamiliarity of the practitioners with video laryngoscopes and their wearing PPE, intubation-related performances were good with the two-channel type video laryngoscopes after the hands-on workshop (all P<0.05).
Conclusion
In preparation for an infectious disease pandemic such as the coronavirus disease 2019 (COVID-19), it would be reasonable to train EMTs who would be wearing PPE on the procedure for intubating a trachea with a channeltype video laryngoscope.
9.Role of non‑pulmonary vein triggers in persistent atrial fibrillation
So Young YANG ; Myung‑Jin CHA ; Hyeon Jeong OH ; Min Soo CHO ; Jun KIM ; Gi‑Byoung NAM ; Kee‑Joon CHOI
International Journal of Arrhythmia 2023;24(1):7-
Pulmonary vein isolation is an well-established treatment strategy for atrial fibrillation (AF), and it is especially effective for patients with paroxysmal AF. However, the success rate is limited for patients with persistent AF, because non-pul‑ monary vein triggers which increase AF recurrence are frequently found in these patients. The major non-pulmonary vein triggers are from the left atrial posterior wall, left atrial appendage, ligament of Marshall, coronary sinus, superior vena cava, and crista terminalis, but other atrial sites can also generate AF triggers. All these sites have been known to contain atrial myocytes with potential arrhythmogenic electrical activity. The prevalence and clinical characteristics of these non-pulmonary vein triggers are well studied; however, the clinical outcome of catheter ablation for persistent AF is still unclear. Here, we reviewed the current ablation strategies for persistent AF and the clinical implications of major non-pulmonary vein triggers.
10.Resting heart rate and cardiovascular outcomes in patients with non‑paroxysmal atrial fibrillation: CODE‑AF registry
Hanjin PARK ; Hee Tae YU ; Tae‑Hoon KIM ; Junbeom PARK ; Jin‑Kyu PARK ; Ki‑Woon KANG ; Jaemin SHIM ; Jin‑Bae KIM ; Jun KIM ; Eue‑Keun CHOI ; HyungWook PARK ; Young Soo LEE ; Boyoung JOUNG
International Journal of Arrhythmia 2023;24(3):15-
Background:
The prognostic significance of resting heart rate and its therapeutic target in atrial fibrillation (AF) is uncertain. We sought to investigate the relationship between resting heart rate and cardiovascular outcomes in patients with non-paroxysmal AF (non-PAF).
Methods:
In this propensity score-weighted, multi-center prospective cohort study, 3217 patients with non-PAF were analyzed. Patients were categorized according to the baseline resting heart rate and cardiovascular outcomes were accessed for a median follow-up of 30 months. The primary outcome was a composite of cardiovascular death, heart failure hospitalization, and myocardial infarction/critical limb ischemia.
Results:
Freedom from primary outcome was longest among patients with resting heart rate 80–99 beats per minute (bpm) whereas shortest among those with ≤ 59 bpm (weighted log rank, p = 0.008). Compared with heart rate ≥ 100 bpm, resting heart rate 80–99 and 60–79 bpm was associated with reduced risk of primary outcome (weighted hazard ratio [WHR] 0.52, 95% confidence interval [CI] 0.32–0.84, p = 0.008 and WHR 0.58, 95% CI 0.37–0.92, p = 0.021 for heart rate 80–99 and 60–79 bpm, respectively). Using weighted restricted cubic spline curves, there was a U-shaped association between the resting heart rate and primary outcome with reduced risk of primary outcome in heart rate range of 68–99 bpm. This association was maintained regardless of atrioventricular node (AVN) blocker use or persistent/permanent AF (p for interaction 0.767 for AVN blocker use and 0.720 for AF type).
Conclusion
Resting heart rate was associated with cardiovascular outcomes in patients with non-PAF and those with resting heart rate between 68 and 99 bpm had lower risk of adverse cardiovascular events regardless of AVN blocker use or persistent/permanent AF.

Result Analysis
Print
Save
E-mail